Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human KCNK15 ELISA Kit (AC3841)
Cat.#: ASET-2430
Specifications
Description Human KCNK15 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human KCNK15 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.019 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1-16 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2006 Mouse UCP3 ELISA Kit (AC3417) Quantitative inquiry ASET-1348 Human Luteinizing Hormone ELISA Kit (AC2759) Quantitative inquiry ASET-2392 Mouse Huntingtin ELISA Kit (AC3803) Quantitative inquiry ASET-1626 Bovine Kisspeptin ELISA Kit (AC3037) Quantitative inquiry ASET-1919 Human LAMP1 ELISA Kit (AC3330) Quantitative inquiry ASET-2058 Mouse C Peptide ELISA Kit (AC3469) Quantitative inquiry ASET-2102 Human Ferritin Light Chain ELISA Kit (AC3513) Quantitative inquiry ASET-2035 Mouse CD11b ELISA Kit (AC3446) Quantitative inquiry ASET-1812 Human Dynamin 2 ELISA Kit (AC3223) Quantitative inquiry ASET-2114 Human SPON2 ELISA Kit (AC3525) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket